Graviton Bioscience - Ownership and Business Overview

Life ScienceCompany

Graviton Bioscience Ownership

Who owns Graviton Bioscience?

Graviton Bioscience is owned by Sanofi SA. It was acquired on February 1, 2024.

Graviton Bioscience Business Overview

Where is Graviton Bioscience headquartered?

Graviton Bioscience is headquartered in New York, New York.

What sector is Graviton Bioscience in?

Graviton Bioscience is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 195 acquisitions of life science companies in 2024, including 17 acquisitions by private equity firms, and 178 by strategics.

Graviton Bioscience

Graviton Bioscience Corp.

125 West End Avenue,
New York, New York 10023
United States,
(646) 366-5120
www.gravitoncorp.com

Graviton Bioscience is a clinical-stage drug discovery and development company, dedicated to engineering and developing best-in-class therapeutics for treating CNS, autoimmune, fibrotic, and other serious diseases where ROCK2 and its other therapeutic compounds play a pivotal role in pathology. Its first drug candidate GV101 is in clinical studies, with additional assets advancing through the preclinical pipeline. Graviton Bioscience is based in New York, New York.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.